[Federal Register Volume 68, Number 97 (Tuesday, May 20, 2003)]
[Notices]
[Page 27566]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-12544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Endocrinologic and Metabolic Drugs Advisory Committee; Amendment 
of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of the meeting of the Endocrinologic and Metabolic Drugs 
Advisory Committee. This meeting was announced in the Federal Register 
of May 6, 2003 (68 FR 24003). The amendment is being made to reflect a 
change in the Agenda portion of the document. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT: Dornette Spell-LeSane, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12536. Please call the Information Line for up-to-date 
information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of May 6, 2003 (68 
FR 24003), FDA announced that a meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee would be held on June 10, 2003. On 
page 24003, in the third column, the Agenda portion of the meeting is 
amended to read as follows:
    Agenda: The committee will discuss supplemental new drug 
application (sNDA) 19-604/S-033 HUMATROPE (somatropin recombinant 
deoxyribonucleic acid (rDNA) origin) for injection), Eli Lilly and Co., 
for the proposed indication of treatment of nongrowth hormone 
deficiency short stature.
    The notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to 
advisory committees.

    Dated: May 13, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-12544 Filed 5-19-03; 8:45 am]
BILLING CODE 4160-01-S